linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Shareholdings  
Glaxosmithkline Pharmaceuticals Ltd.
 
BSE Code 500660
ISIN Demat INE159A01016
Book Value 116.88
NSE Code GLAXO
Dividend Yield % 2.29
Market Cap 400179.40
P/E 40.14
EPS 58.85
Face Value 10  
Description ( As On March 2026 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter          
  Foreign Promoter  4  127054524  75  127054524  
  Total Promoter  4  127054524  75  127054524  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI  36  8010653  4.73  7997533  
  FI/Bank/Insurance  39  4603735  2.72  4583849  
  Govt  2  94    94  
  FII  1  50    50  
  Other  247  8229338  4.85  8229338  
  Total Institutions  325  20843820  12.3  20810814  
 Non-Institution          
  Bodies Corporate  992  1475985  0.87  1463735  
  Individuals          
  NRIs/OCBs  4095  876897  0.52  869969  
  Others  116347  19154808  11.31  18062240  
  Total Non-Institution  121434  21507690  12.7  20395944  
Total Non Promoter  121759  42351510  25  41206758  
          
  Depository Receipts          
          
Grand Total  121763  169406034  100  168261282  
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.